NCT00207025View on ClinicalTrials.gov

A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies

PHASE1TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

February 28, 2007

Conditions
Tumors
Interventions
DRUG

BMS-275183

Trial Locations (3)

Unknown

Local Institution, Detroit

Local Institution, Pittsburgh

Local Institution, Brussels

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY